Recent Updates
Recently added Catalysts
BSX

Boston Scientific to Participate in 2011 Wells Fargo Securities Healthcare Conference Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2011 Wells Fargo Securities Healthcare Conference on June 22 in Boston....

Key Takeaway: NATICK, Mass. , June 16, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the 2011 Wells Fargo Securities Healthcare Conference on June 22 in Boston . Ray Elliott , President and Chief Executive Officer, and Jeff Capello , Executive

Full Press Release Details

NATICK, Mass. , June 16, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the 2011 Wells Fargo Securities Healthcare Conference on June 22 in Boston .
Ray Elliott , President and Chief Executive Officer, and Jeff Capello , Executive Vice President and Chief Financial Officer, will participate in a 25-minute Q&A discussion about the Company beginning at approximately 9:00 a.m. ET .
A live webcast of the discussion will be available via Boston Scientific's website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors . Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
This webcast is being hosted by Wells Fargo. The replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the discussion.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com .
CONTACT: Erik Kopp
(508) 650-8660 (office)
Media Relations
Boston Scientific Corporation
[email protected]
Sean Wirtjes
(508) 652-5305 (office)
Investor Relations
Boston Scientific Corporation
[email protected]
SOURCE Boston Scientific Corporation

21 %

Last updated: Jun 16, 2011